77 related articles for article (PubMed ID: 6912076)
1. Treatment re-entry and outcomes of opioid addicts during a four-year follow-up after drug abuse treatment in the United States.
Simpson DD; Savage LJ
Bull Narc; 1980; 32(4):1-10. PubMed ID: 6912076
[TBL] [Abstract][Full Text] [Related]
2. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
[TBL] [Abstract][Full Text] [Related]
3. The nature and status of drug abuse treatment.
Nurco DN; Kinlock TW; Hanlon TE
Md Med J; 1994 Jan; 43(1):51-7. PubMed ID: 8183085
[TBL] [Abstract][Full Text] [Related]
4. Status of opioid addicts 5 years after admission to drug abuse treatment.
Bracy SA; Simpson DD
Am J Drug Alcohol Abuse; 1982-1983; 9(2):115-27. PubMed ID: 7171076
[TBL] [Abstract][Full Text] [Related]
5. Drug abuse treatment readmissions and outcomes. Three-year follow-up of DARP patients.
Simpson DD; Savage LJ
Arch Gen Psychiatry; 1980 Aug; 37(8):896-901. PubMed ID: 7406653
[TBL] [Abstract][Full Text] [Related]
6. [Detoxification from opiates through hospitalization: the long-term results. A longitudinal study of 104 admissions in 1982-1986].
Morino U; Nobili M; Vivalda L
Minerva Med; 1991 Apr; 82(4):201-5. PubMed ID: 2017316
[TBL] [Abstract][Full Text] [Related]
7. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
Goeb JL; Coste J; Bigot T; Ferrand I
Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
[TBL] [Abstract][Full Text] [Related]
8. Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment.
Torrens M; San L; Martinez A; Castillo C; Domingo-Salvany A; Alonso J
Addiction; 1997 Jun; 92(6):707-16. PubMed ID: 9246798
[TBL] [Abstract][Full Text] [Related]
9. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of drug and alcohol counselling during methadone treatment: content, frequency, and duration of counselling and association with substance use outcomes.
Gossop M; Stewart D; Marsden J
Addiction; 2006 Mar; 101(3):404-12. PubMed ID: 16499513
[TBL] [Abstract][Full Text] [Related]
11. The relation of time spent in drug abuse treatment to posttreatment outcome.
Simpson DD
Am J Psychiatry; 1979 Nov; 136(11):1449-53. PubMed ID: 495799
[TBL] [Abstract][Full Text] [Related]
12. Legal status and long-term outcomes for addicts in the DARP followup project.
Simpson DD; Friend HJ
NIDA Res Monogr; 1988; 86():81-98. PubMed ID: 3140037
[No Abstract] [Full Text] [Related]
13. Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial.
Robertson JR; Raab GM; Bruce M; McKenzie JS; Storkey HR; Salter A
Addiction; 2006 Dec; 101(12):1752-9. PubMed ID: 17156174
[TBL] [Abstract][Full Text] [Related]
14. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
[TBL] [Abstract][Full Text] [Related]
16. Depression and hostility as predictors of long-term outcomes among opiate users.
Rao SR; Broome KM; Simpson DD
Addiction; 2004 May; 99(5):579-89. PubMed ID: 15078232
[TBL] [Abstract][Full Text] [Related]
17. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
Fhima A; Henrion R; Lowenstein W; Charpak Y
Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
[TBL] [Abstract][Full Text] [Related]
18. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
[TBL] [Abstract][Full Text] [Related]
19. Sexual abuse history and treatment outcomes among women undergoing methadone treatment.
Bartholomew NG; Courtney K; Rowan-Szal GA; Simpson DD
J Subst Abuse Treat; 2005 Oct; 29(3):231-5. PubMed ID: 16183472
[TBL] [Abstract][Full Text] [Related]
20. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
